Results 141 to 150 of about 11,283,677 (180)

Donor-derived CARCIK-CD19 cells engineered with Sleeping Beauty transposon in acute lymphoblastic leukemia relapsed after allogeneic transplantation. [PDF]

open access: yesBlood Cancer J
Lussana F   +32 more
europepmc   +1 more source

Ongoing complete remissions in phase 1 of ZUMA-1: a phase 1-2 multi-center study evaluating the safety and efficacy of KTE-C19 (anti-CD19 CAR T cells) in patients with refractory aggressive B cell non-Hodgkin lymphoma (NHL)

open access: yes, 2016
F. Locke   +15 more
semanticscholar   +1 more source

Abstracts of the Cell Therapy Transplant Canada 2024 Annual Conference. [PDF]

open access: yesCurr Oncol
Maier SA   +16 more
europepmc   +1 more source

745. Updated Phase 1 Results from ZUMA-1: A Phase 1-2 Multi-Center Study Evaluating the Safety and Efficacy of KTE-C19 (Anti-CD19 CAR T Cells) in Subjects with Refractory Aggressive Non-Hodgkin Lymphoma (NHL)

open access: yes, 2016
F. Locke   +14 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy